← Back to Search

Sound Modulation for Critical Illness (SMART Trial)

N/A
Waitlist Available
Led By Brian K Gehlbach, MD
Research Sponsored by Brian Gehlbach
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects aged 18-99 years who are expected to receive care on an adult critical care unit for at least 24 hours
Be older than 18 years old
Must not have
Use of vasopressors
Use of hearing aids, or known significant conductive or sensory hearing loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at the time of hospital discharge up to a maximum of 28 days after enrollment, and averaging 6 days after enrollment.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how well two different types of noise-reduction help ICU patients manage stress-related physiological parameters.

Who is the study for?
This trial is for adults aged 18-99 in critical care expected to stay at least 24 hours. It's not for those with significant hearing loss, drug overdose, substance abuse disorders, untreated sleep disorders, on vasopressors, unresponsive or delirious patients, or those with dementia or neurodegenerative diseases.
What is being tested?
The study tests if sound masking and noise reduction can lower stress in ICU patients. Participants will experience modified sound environments to see if these changes improve their physiological responses related to stress.
What are the potential side effects?
Since the interventions involve sound modulation rather than medication or invasive procedures, side effects are minimal but may include discomfort due to changes in usual noise levels.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 99 years old and will be in intensive care for at least a day.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently on medication to raise my blood pressure.
Select...
I use hearing aids or have significant hearing loss.
Select...
I have not been treated for any sleep disorders.
Select...
I am on a ventilator through a tube in my windpipe.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at the time of icu discharge up to a maximum of 28 days after enrollment, and averaging 4 days after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at the time of icu discharge up to a maximum of 28 days after enrollment, and averaging 4 days after enrollment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nocturnal LF/HF ratio (a.u.)
Secondary study objectives
Discharged home (%, versus discharge to another health care facility or died)
Hospital length of stay (days)
Hospital mortality (%)
+5 more
Other study objectives
Intra-individual nocturnal LF/HF ratio (a.u.)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Usual CareActive Control1 Intervention
Usual care will be provided.
Group II: Sound maskingActive Control1 Intervention
Use of headphones and relaxing music. Sennheiser HD 280 pro headphones will be used for sound masking.
Group III: Sound reductionActive Control1 Intervention
Use of noise reduction headphones. Pro For Sho safety ear muffs with a noise reduction rate of 34dB will be used.

Find a Location

Who is running the clinical trial?

Brian GehlbachLead Sponsor
1 Previous Clinical Trials
24 Total Patients Enrolled
1 Trials studying Critical Illness
24 Patients Enrolled for Critical Illness
Brian K Gehlbach, MDPrincipal InvestigatorFaculty
3 Previous Clinical Trials
597 Total Patients Enrolled
3 Trials studying Critical Illness
597 Patients Enrolled for Critical Illness

Media Library

Sound masking Clinical Trial Eligibility Overview. Trial Name: NCT03019133 — N/A
Critical Illness Research Study Groups: Usual Care, Sound masking, Sound reduction
Critical Illness Clinical Trial 2023: Sound masking Highlights & Side Effects. Trial Name: NCT03019133 — N/A
Sound masking 2023 Treatment Timeline for Medical Study. Trial Name: NCT03019133 — N/A
~1 spots leftby Dec 2024